Neoplas Med featured in the Venture Capital Magazine

Our unique precision technology, combined with scientific excellence, defines our core strength’ explains Ulrike Sailer in the latest Impact Life Sciences issue by VentureCapital Magazin.

We are proud to see Neoplas Med featured as the pioneer in argon jet coldplasma therapy – operating from the heart of Greifswald’s vibrant innovation ecosystem. As a leading force within the Jetplasma Cluster Greifswald and in close collaboration with leading research institutions and the University Hospital Center, we are perfectly positioned to bring cutting-edge medical technology from lab to clinic.

Our flagship product, the argon cold plasma jet kINPen® MED, is the first clinically validated and MDR-certified device of its kind. Used in over 75% of university hospitals across the DACH region, with “lighthose” clinics in Middle East and with more than 500,000 applications and 400+ studies, we are redefining the standard of wound care.

Read the full article here: https://bc-production.pressmatrix.com/de/profiles/98d522283e29/editions/4af93f1672d56defddac/pages/page/9